Nissan Medical Industries Ltd (TLV:NISA)
Israel · Delayed Price · Currency is ILS · Price in ILA 966.10
+17.40 (1.83%)
At close: Jan 30, 2026
Nissan Medical Industries Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 0 | 7.91 | 5.65 | -36.05 | 36.01 | 56.85 |
Depreciation & Amortization | 28.61 | 29.64 | 31.14 | 28.65 | 25.6 | 27.42 |
Loss (Gain) From Sale of Assets | -2.76 | 0 | 0.15 | -0.04 | 0.07 | -0.08 |
Asset Writedown & Restructuring Costs | - | - | - | 23.79 | - | - |
Loss (Gain) From Sale of Investments | -0.09 | -0.01 | -0.01 | 0.05 | -5.39 | -0.68 |
Loss (Gain) on Equity Investments | -2.32 | -1.3 | 7.06 | 0.64 | -4.62 | -10.66 |
Stock-Based Compensation | 0.62 | 1.18 | 0.58 | 0.27 | 1.45 | 3.03 |
Other Operating Activities | 10.63 | 17.06 | 34.13 | 3.61 | 25.89 | 52.24 |
Change in Accounts Receivable | -11.82 | 20.61 | 33.8 | -19.71 | -16.45 | -21.89 |
Change in Inventory | 22.45 | -54.41 | -6.07 | 8.41 | -52 | 9.37 |
Change in Accounts Payable | -8.8 | 7.08 | -7.41 | 5.29 | 12.21 | 2.02 |
Change in Other Net Operating Assets | -2.14 | -0.94 | 6.69 | -3.22 | -4.8 | 4.95 |
Operating Cash Flow | 34.37 | 26.83 | 105.72 | 11.67 | 17.98 | 122.57 |
Operating Cash Flow Growth | -51.88% | -74.62% | 805.56% | -35.07% | -85.33% | 122.80% |
Capital Expenditures | -18.86 | -6.09 | -9.82 | -9.18 | -8.16 | -13.86 |
Sale of Property, Plant & Equipment | 0.06 | 0.03 | 0.26 | 0.17 | 0.03 | 0.23 |
Sale (Purchase) of Intangibles | -0.12 | -0.21 | -0.36 | -0.51 | -0.14 | -0.05 |
Investment in Securities | 1.14 | 13.79 | - | -0.15 | 8.42 | 0.59 |
Other Investing Activities | 10.34 | -11.39 | - | - | 5.48 | 0.66 |
Investing Cash Flow | -7.44 | -3.87 | -9.93 | -9.68 | 5.62 | -12.42 |
Short-Term Debt Issued | - | 23.92 | 6.82 | 13.37 | - | - |
Long-Term Debt Issued | - | 49.11 | 0.5 | 42.71 | 89.91 | 80.73 |
Total Debt Issued | 74.27 | 73.03 | 7.32 | 56.08 | 89.91 | 80.73 |
Short-Term Debt Repaid | - | - | - | - | -3.42 | -42.16 |
Long-Term Debt Repaid | - | -75.41 | -73.67 | -66.82 | -80.87 | -79.12 |
Total Debt Repaid | -75.99 | -75.41 | -73.67 | -66.82 | -84.29 | -121.28 |
Net Debt Issued (Repaid) | -1.72 | -2.38 | -66.35 | -10.75 | 5.61 | -40.55 |
Common Dividends Paid | -6.81 | -6.81 | - | -4 | -9.08 | -9.99 |
Other Financing Activities | -13.37 | -23.18 | -24.36 | -11.04 | -27.73 | -29.72 |
Financing Cash Flow | -21.9 | -32.37 | -90.71 | -25.78 | -31.2 | -80.26 |
Foreign Exchange Rate Adjustments | -2.2 | 0.26 | 0.46 | 3.03 | -0.88 | -2.87 |
Net Cash Flow | 2.83 | -9.14 | 5.53 | -20.75 | -8.48 | 27.01 |
Free Cash Flow | 15.51 | 20.74 | 95.9 | 2.49 | 9.82 | 108.71 |
Free Cash Flow Growth | -75.28% | -78.37% | 3745.07% | -74.60% | -90.97% | 142.19% |
Free Cash Flow Margin | 2.42% | 3.12% | 13.07% | 0.36% | 1.47% | 15.07% |
Free Cash Flow Per Share | 1.78 | 2.28 | 10.56 | 0.28 | 1.08 | 11.97 |
Cash Interest Paid | 13.37 | 13.79 | 16.31 | 11.04 | 10.11 | 10.44 |
Cash Income Tax Paid | 4.28 | 6.29 | 9.3 | 2.34 | 11.64 | 7.89 |
Levered Free Cash Flow | 30.41 | 5.89 | 54.04 | -4.51 | -1.37 | 73.13 |
Unlevered Free Cash Flow | 38.13 | 14.23 | 67.33 | 1.75 | 3.18 | 79 |
Change in Working Capital | -0.31 | -27.65 | 27.02 | -9.24 | -61.03 | -5.54 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.